BCAL Diagnostics (ASX:BDX) Other Current Payables : A$0.00 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is BCAL Diagnostics Other Current Payables?

BCAL Diagnostics's Other Current Payables for the quarter that ended in Dec. 2023 was A$0.00 Mil.

BCAL Diagnostics's quarterly Other Current Payables increased from Dec. 2022 (A$0.00 Mil) to Jun. 2023 (A$0.44 Mil) but then declined from Jun. 2023 (A$0.44 Mil) to Dec. 2023 (A$0.00 Mil).

BCAL Diagnostics's annual Other Current Payables increased from . 20 (A$0.00 Mil) to Jun. 2022 (A$0.64 Mil) but then declined from Jun. 2022 (A$0.64 Mil) to Jun. 2023 (A$0.44 Mil).

BCAL Diagnostics Other Current Payables Historical Data

The historical data trend for BCAL Diagnostics's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BCAL Diagnostics Other Current Payables Chart

BCAL Diagnostics Annual Data

Trend

Jun22

Jun23

Other Current Payables

0.64

0.44

BCAL Diagnostics Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Other Current Payables	Get a 7-Day Free Trial			-	0.64	-	0.44	-

BCAL Diagnostics Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

BCAL Diagnostics Other Current Payables Related Terms

Thank you for viewing the detailed overview of BCAL Diagnostics's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

BCAL Diagnostics (ASX:BDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BCAL Diagnostics Ltd (ASX:BDX) » Definitions » Other Current Payables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Queen Victoria Building, GPO Box Q128, Sydney, NSW, AUS, 1230

Website

https://www.bcaldiagnostics.com

BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.